Attached files
file | filename |
---|---|
10-Q - Statera Biopharma, Inc. | v193614_10q.htm |
EX-31.1 - Statera Biopharma, Inc. | v193614_ex31-1.htm |
EX-10.1 - Statera Biopharma, Inc. | v193614_ex10-1.htm |
EX-31.2 - Statera Biopharma, Inc. | v193614_ex31-2.htm |
Exhibit
32.1
Certification*
In
connection with the Quarterly Report of Cleveland BioLabs, Inc., (the
“Company”), on Form 10-Q for the quarter ending June 30, 2010 as filed with the
Securities and Exchange Commission on the date hereof (the “Periodic Report”)
pursuant to the requirement set forth in Rule 13a-14(b) of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), and Section 1350 of
Chapter 63 of Title 18 of the United States Code (18 U.S.C.§ 1350), Michael
Fonstein, Chief Executive Officer of the Company, and John A. Marhofer, Jr.,
Chief Financial Officer of the Company, each hereby certifies that, to the best
of his knowledge:
1. The
Periodic Report fully complies with the requirements of Section 13(a) or Section
15(d) of the Exchange Act, and
2. The
information contained in the Periodic Report fairly presents, in all material
respects, the financial condition and results of operations of the Company for
the period covered by the Periodic Report.
Dated:
August 16, 2010
|
By:
|
/s/
Michael Fonstein
|
|
Michael
Fonstein
|
|||
Chief
Executive Officer
|
|||
(Principal
Executive Officer)
|
Dated:
August 16, 2010
|
By:
|
/s/
John A. Marhofer, Jr.
|
|
John
A. Marhofer, Jr.
|
|||
Chief
Financial Officer
|
|||
(Principal
Financial and Accounting Officer)
|
*
|
This
certification accompanies the Periodic Report to which it relates, is not
deemed filed with the Securities and Exchange Commission and is not to be
incorporated by reference into any filing of Cleveland BioLabs, Inc. under
the Securities Act of 1933, as amended, or the Securities Exchange Act of
1934, as amended (whether made before or after the date of the Periodic
Report), irrespective of any general incorporation language contained in
such filing.
|